Hoxton Planning & Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Hoxton Planning & Management's AZN Position: Q3 2026 in Review
Hoxton Planning & Management reduced its AstraZeneca (AZN) stake by 13% in Q3 2026, selling an estimated $32.7K and leaving 1,308 shares worth $211K. The position accounts for 0.05% of the portfolio, ranked #218.
Hoxton Planning & Management first reported a position in AZN in Q2 2024 and has held it in 7 quarters since. The position peaked at $289K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Hoxton Planning & Management held 1,308 shares of AstraZeneca worth $211K as of Q3 2026.
- Hoxton Planning & Management sold 196 AstraZeneca shares in Q3 2026, an estimated $32.7K.
- AstraZeneca made up 0.05% of Hoxton Planning & Management's portfolio in Q3 2026, its #218 holding.
- Hoxton Planning & Management first reported a position in AstraZeneca in Q2 2024 and has held it in 7 quarters since.
- Hoxton Planning & Management's AstraZeneca position peaked at $289K in Q1 2026.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Hoxton Planning & Management's 13F filing for Q3 2026, filed 15 Oct 2026.